Dr Fazliny Abdul Rahman has marked a momentous year, achieving groundbreaking milestones for herself and the Faculty of Dentistry at SEGi University.
Her pioneering research collaboration with NiSCELL, Malaysia’s first cell therapy company specialising in stem cells and immunotherapy, is a testament to her commitment to innovation. The project, titled ‘Potential Role of Dental Pulp Stem Cells Conditioned Medium (DPSC-CM) for Autism Spectrum Disorder (ASD) and Neuronal Regeneration of Dental Pulp Stem Cells,’ explores the potential of stem cell applications in transformative therapies.
As the principal investigator, Dr Fazliny is leading this groundbreaking initiative in collaboration with a NiSCELL researcher. NiSCELL’s substantial investment of RM150,000 underscores their confidence in this project’s potential impact. This partnership is further strengthened by an upcoming memorandum of understanding (MoU) between SEGi University and NiSCELL, paving the way for long-term collaboration.
Adding to her remarkable year, Dr Fazliny secured SEGi’s first Fundamental Research Grant Scheme (FRGS) from the Ministry of Higher Education. Her project, ‘Gene Expression Profiling Reveals Markers Promoting Osteoblast Potential in Dental Pulp Stem Cells Treated with Aspirin,’ received a grant of RM138,940 and will run from October 2023 to September 2026.
This collaborative endeavour includes researchers from SEGi University and the Faculty of Dentistry at the University of Malaya (UM), showcasing the project’s wide-reaching significance. By uniting expertise across institutions, this research aims to unlock new possibilities in dental and regenerative medicine.
Dr Fazliny’s dual achievements highlight her position as a leader in cutting-edge research, pushing the boundaries of science in dentistry and stem cell therapies.
Congratulations, Dr Fazliny, on these incredible accomplishments! Your dedication inspires us, and SEGi University is proud to support your journey toward transforming lives through innovative research.